Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
CBL-514 by Caliway Biopharmaceutics for Cellulite: Likelihood of Approval
CBL-514 is under clinical development by Caliway Biopharmaceutics and currently in Phase II for Cellulite. According to GlobalData, Phase II...
Data Insights
CBL-514 by Caliway Biopharmaceutics for Cellulite: Likelihood of Approval
CBL-514 is under clinical development by Caliway Biopharmaceutics and currently in Phase II for Cellulite. According to GlobalData, Phase II...